Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report)’s share price was down 1.9% on Friday . The company traded as low as GBX 26 ($0.33) and last traded at GBX 26.50 ($0.33). Approximately 49,264 shares traded hands during trading, a decline of 85% from the average daily volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.34).
Mereo BioPharma Group plc (MPH.L) Stock Performance
The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98. The company has a market cap of £89.76 million and a PE ratio of -0.21. The company’s 50 day moving average price is GBX 26.50 and its 200-day moving average price is GBX 26.50.
About Mereo BioPharma Group plc (MPH.L)
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Articles
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- High Flyers: 3 Natural Gas Stocks for March 2022
- Tesla Investors Continue to Profit From the Trump Trade
- Investing In Automotive Stocks
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
